MedTrace Logo

Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode Impedance

NCT02794233 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-05-15

No results posted yet for this study

Summary

The study will look into the changes of Deep Brain Stimulation (DBS) measured impedances in patients of Parkinson disease (PD) as a function of their functional state (lying, sitting and walking) and dopaminergic medication intake (levodopa or dopamine agonists).

The goal is to use DBS measured impedance as a surrogate of the functional and medication states of PD patients.

Conditions

  • Parkinson Disease

Interventions

OTHER

Impedance measurements

Refer to study description

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Leonardo Brito de Almeida, MD · University of Florida

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794233 on ClinicalTrials.gov